OXTELLAR XR
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
17772-123 -
Package NDC
17772-123-01 -
Package NDC
17772-123-07 -
Package NDC
17772-123-10 -
Application number
NDA202810 -
SPL ID
5d1a0e22-40aa-c6f7-e063-6394a90a48dc -
SPL set ID
aa610e56-1d1d-11e1-8bc2-0800200c9a66 -
UNII
VZI5B1W380 -
RxCUI
1365653 -
RxCUI
1365660 -
RxCUI
1365842 -
RxCUI
1365844 -
RxCUI
1365847 -
RxCUI
1365850
What the source publishes
- Labeler
- Supernus Pharmaceuticals, Inc.
- Active ingredients
- OXCARBAZEPINE
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "OXTELLAR XR",
"splId": "5d1a0e22-40aa-c6f7-e063-6394a90a48dc",
"labels": [
{
"setId": "aa610e56-1d1d-11e1-8bc2-0800200c9a66",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa610e56-1d1d-11e1-8bc2-0800200c9a66",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa610e56-1d1d-11e1-8bc2-0800200c9a66"
}
],
"routes": [
"ORAL"
],
"labeler": "Supernus Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (17772-123-01)",
"package_ndc": "17772-123-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20130117"
},
{
"sample": true,
"description": "7 TABLET in 1 BOTTLE (17772-123-07)",
"package_ndc": "17772-123-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20230701"
},
{
"sample": true,
"description": "5 TABLET in 1 BLISTER PACK (17772-123-10)",
"package_ndc": "17772-123-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20130117"
}
],
"productId": "17772-123_5d1a0e22-40aa-c6f7-e063-6394a90a48dc",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "17772-123",
"deaSchedule": null,
"genericName": "OXCARBAZEPINE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "OXCARBAZEPINE",
"strength": "600 mg/1"
}
],
"applicationNumber": "NDA202810",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20130117",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175753",
"N0000008486"
],
"upc": [
"0317772123012",
"0317772121018",
"0317772122015"
],
"unii": [
"VZI5B1W380"
],
"rxcui": [
"1365653",
"1365660",
"1365842",
"1365844",
"1365847",
"1365850"
],
"spl_set_id": [
"aa610e56-1d1d-11e1-8bc2-0800200c9a66"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"pharm_class_epc": [
"Anti-epileptic Agent [EPC]"
],
"manufacturer_name": [
"Supernus Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:17772-123_5d1a0e22-40aa-c6f7-e063-6394a90a48dc"